Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT04229134
Piloting a Novel Peer Support Pain Self-Management Intervention (Projec…
Piloting a Novel Peer Support Pai… Myopathies Non applicable COMPLETED En attente / non publié VA Office of Research and Develop… United States · VA Connecticut Healthcare System West… 2021-05-05 → 2025-05-30 Ouvrir
NCT06082518
PCS-HBOT — Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Trea…
Monoplace Hyperbaric Chamber (Cla… Myopathies Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Sunnybrook Health Sciences Centre Canada · Sunnybrook Health Sciences Centre, Toronto, … 2024-01-02 → 2027-07 Ouvrir
NCT06697717
End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance T…
End-expiratory Transpulmonary Pre… Myopathies Non applicable COMPLETED En attente / non publié XiaoJing Zou,MD China · Wuhan Union Hospital, Wuhan, China 2024-12-31 → 2026-02-20 Ouvrir
NCT06582134
Effectiveness of Brief Mindfulness-Based Interventions for Painful Temp…
Effectiveness of Brief Mindfulnes… Myopathies Non applicable COMPLETED En attente / non publié University of Malaya Malaysia · Oral Medicine Clinic, Faculty of Dentisty,… 2024-01-12 → 2025-09-30 Ouvrir
NCT06154252
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy…
CABA-201 following preconditionin… Myopathies Phase 2/3 RECRUITING En attente / non publié Cabaletta Bio United States, United Kingdom · Ann & Robert H. Lurie… 2023-12-20 → 2028-07 Ouvrir
NCT07511556
First-in-human Study of UX016 in GNEM
UX016 Myopathies Phase 1/2 RECRUITING En attente / non publié Ultragenyx Pharmaceutical Inc United States · Clinical Trial Site, Orange, United S… 2026-10 → 2028-12 Ouvrir
NCT07395154
INIT ART — Comparison of Integrated Neuromuscular Inhibition Technique …
INIT ART — Comparison of Integrat… Myopathies Non applicable COMPLETED En attente / non publié Lahore University of Biological a… Pakistan · Lahore University of Biological and Applie… 2026-02-15 → 2026-06-30 Ouvrir
NCT05292339
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
Triamcinolone injection to the sh… Myopathies Phase 4 RECRUITING En attente / non publié Emory University United States · 12 Executive Park Drive, Atlanta, Uni… 2023-01-31 → 2027-07 Ouvrir
NCT07286435
The Effect of Whole-Body Vibration Therapy Following Botulinum Toxin A …
Whole body vibration therapy Myopathies Non applicable RECRUITING En attente / non publié Uludag University Turkey (Türkiye) · Bursa Uludağ University Faculty of… 2026-01-05 → 2027-12 Ouvrir
NCT07802938
Pulsed Electromagnetic Field Therapy Added to ESWT for Lateral Epicondy…
Pulsed Electromagnetic Field Ther… Myopathies Non applicable NOT_YET_RECRUITING En attente / non publié Ali Güneri Non communiqué 2026-09-02 → 2027-01-14 Ouvrir
NCT03199469
ASPIRO — A Study of AT132 in Young Children With X-Linked Myotubular My…
Resamirigene bilparvovec Myopathies Phase 2/3 ACTIVE_NOT_RECRUITING En attente / non publié Astellas Gene Therapies United States, Canada, France, Germany · Ann & Robert… 2017-08-02 → 2030-03-31 Ouvrir
NCT07792434
The NAP SAPS — Nociplastic Pain in Patients Diagnosed With Subacromial …
Clinical evaluation Myopathies À vérifier NOT_YET_RECRUITING En attente / non publié Vejle Hospital Denmark · Vejle Hospital, Vejle, Denmark 2026-09-15 → 2028-08 Ouvrir
NCT07792421
NAP SAPS CSI — Pain Phenotype and Response to Corticosteroid Injection …
Clinical evaluation Myopathies À vérifier NOT_YET_RECRUITING En attente / non publié Vejle Hospital Denmark · Vejle Hospital, Vejle, Denmark 2026-09-15 → 2028-11-30 Ouvrir
NCT05257473
GRASP-01-002 — Defining Endpoints in Becker Muscular Dystrophy
GRASP-01-002 — Defining Endpoints… Myopathies À vérifier ACTIVE_NOT_RECRUITING En attente / non publié Virginia Commonwealth University United States, New Zealand, United Kingdom · John Wal… 2022-04-13 → 2026-09-30 Ouvrir
NCT07486934
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) …
zeleciment basivarsen (DYNE-101) Myopathies Phase 3 RECRUITING En attente / non publié Dyne Therapeutics United States, Australia, Belgium, Denmark, France, G… 2026-05-14 → 2029-01 Ouvrir
NCT06314282
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anif…
INTERSTELLAR - International Stud… Lupus À vérifier RECRUITING En attente / non publié AstraZeneca Argentina, China, Costa Rica, Egypt, Guatemala, Kazak… 2024-10-22 → 2027-12-31 Ouvrir
NCT06925542
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Re…
CTX112 Lupus Phase 1 RECRUITING En attente / non publié CRISPR Therapeutics United States, Germany, Spain · Boston Medical Center… 2025-03-10 → 2031-12-31 Ouvrir
NCT06411249
A Study Describing the Efficacy and Safety of Belimumab Administered in…
Belimumab (GSK1550188) Lupus Phase 4 ACTIVE_NOT_RECRUITING En attente / non publié GlaxoSmithKline United States, Argentina, Brazil, France, Germany, Gr… 2024-06-06 → 2029-07-17 Ouvrir
NCT07570862
RECLAIM-LN — A Phase 2, Open-Label, Single-Arm Trial of FT819 in Partic…
FT819 Lupus Phase 2 RECRUITING En attente / non publié Fate Therapeutics United States · Cross Creek Medical Clinic, Fayettevi… 2026-07-27 → 2030-01-31 Ouvrir
NCT06581198
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus…
rapcabtagene autoleucel Lupus Phase 2 ACTIVE_NOT_RECRUITING En attente / non publié Novartis Pharmaceuticals United States, Argentina, Australia, Austria, Brazil,… 2024-09-04 → 2032-02-06 Ouvrir
NCT07215663
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
Cizutamig Lupus Phase 1 RECRUITING En attente / non publié Candid Therapeutics China · Chinese Academy of Medical Sciences and Pekin… 2025-09-04 → 2028-04 Ouvrir
NCT06659029
PRIMULA_Preg — Prospective Registry Investigating Maternal and Infant O…
Anifrolumab Lupus À vérifier RECRUITING En attente / non publié AstraZeneca United States · Research Site, Wilmington, United Sta… 2025-07-01 → 2031-04-15 Ouvrir
NCT07276958
A Study of LY4298445 in Healthy Participants and Participants With Syst…
LY4298445 Lupus Phase 1 RECRUITING En attente / non publié Eli Lilly and Company Australia, China · Anhui Provincial Hospital, Hefei, … 2026-02-04 → 2028-03 Ouvrir
NCT07791199
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO…
Deucravacitinib Lupus Phase 3 NOT_YET_RECRUITING En attente / non publié Bristol-Myers Squibb Non communiqué 2026-12-31 → 2030-10-31 Ouvrir
NCT06524570
iFOCUS — Treatment of Cancer With Immune Checkpoint Inhibition Therapy …
Histotripsie — HistoSonics Edison… Cancer Phase 1 RECRUITING En attente / non publié National Taiwan University Hospit… Netherlands · University Medical Center Utrecht, Utre… 2024-07-26 → 2030-08-01 Ouvrir